Gilselena Kerbauy, Ana C P Vivan, Glenda C Simões, Ane S Simionato, Marsileni Pelisson, Eliana C Vespero, Silvia F Costa, Celia G T de J Andrade, Daiane M Barbieri, João C P Mello, Alexandre T Morey, Lucy M Yamauchi, Sueli F Yamada-Ogatta, Admilton G de Oliveira, Galdino Andrade
Multidrug-resistant organisms (MDRO) are a great problem in hospitals, where thousands of people are infected daily, with the occurrence of high mortality rates, especially in infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-producing Kpn). The challenge is to find new compounds that can control KPC producing-Kpn infections. The aim of this study was to evaluate the antibiotic activity of the F3d fraction produced by the Pseudomonas aeruginosa LV strain against clinical isolates of KPC-producing Kpn...
2016: Current Pharmaceutical Biotechnology